Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale
1 other identifier
observational
80
1 country
1
Brief Summary
We will validate the French version of the "Patients' Endorsement of a Biopsychosocial model of chronic pain (PEB) scale" by comparing it to the "pain self-efficacy" questionnaire
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 26, 2026
CompletedMarch 19, 2026
March 1, 2026
1.3 years
November 18, 2024
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incremental validity of the new ABDC scale
Incremental validity is the degree to which a new scale increases the ability to predict an outcome beyond existing parameters and scales. In our case pain self-efficacy, measured by the "pain self-efficacy questionnaire" \[8\], which exists in a validated French version \[9\], is the outcome to be predicted. Hierarchical regression analysis will have four models including in hierarchical order 8 explanatory variables: demographical variables (gender, age, level of education), depressive symptoms and anxiety, pain catastrophizing, pain acceptance, and finally the ABDC scale
1 day
Secondary Outcomes (3)
Reliability of the ABDC scale
1 day
Convergent validity
1 day
Discriminant validity
1 day
Eligibility Criteria
patients treated by the ambulatory chronic pain clinic (consultation d'antalgie) of the HUG
You may qualify if:
- \- Patients with chronic pain (defined by ICD-11 as pain persisting or recurring longer than 3 months) having a chronic pain consultation at the HUG
- French-speaking and able to understand the study information
- ≥18 years of age
You may not qualify if:
- \- Inability to understand the consent form and the questionnaire, e.g. due to lan-guage problems, psychological disorders, dementia, etc. of the participant
- Enrolment of the investigator, his/her family members, employees and other de-pendent persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpitaux Universitaires de Genève
Geneva, 1205, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical professor
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 21, 2024
Study Start
November 1, 2024
Primary Completion
February 26, 2026
Study Completion
February 26, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share